Product ReviewsBEIJING, Feb. 4, 2022 On February 4, 2022, the whole world watched the Opening Ceremony for the Beijing Winter Olympics. This grand event provided a stunning visual feast that combined digital technology and beautiful creative designs. It was not only technologically advanced, but…
SAN DIEGO, Feb. 4, 2022 /PRNewswire/ — PriceSmart, Inc. (NASDAQ: PSMT), operator of 49 warehouse clubs in 12 countries and one U.S. territory, today announced a 22.9% increase to its annual dividend, the election of one new member to the Board of Directors and the results of the…
BETHESDA, Maryland et SOLEURE, Suisse, 5 février 2022 /PRNewswire/ — Brivo, Inc., le leader mondial des technologies de contrôle d’accès et de bâtiments intelligents basées sur le cloud qui a récemment conclu un accord de fusion définitif avec Crown PropTech Acquisitions (NYSE: CPTK),…
KINGSTON, N.Y., Feb. 4, 2022 /PRNewswire/ — Coldwell Banker Real Estate agents know the value of home; they’ve been guiding people home since 1906. St. Jude Children’s Research Hospital®️ treats more than 8,500 kids a year for cancer and other life-threatening diseases. Children and…
NEW YORK, Feb. 4, 2022 /PRNewswire/ — As the new waves of the Omicron variety gain strength around the world, work-from-home, study-from-home and socialize-from-home models have been integrated by governments. The World Economic Forum has identified 5 dangers which harm our health during…
DUBLIN, Feb. 4, 2022 /PRNewswire/ — Modmo closed out 2021 with a €5m investment from Ballymore Group CEO Sean Mulryan, in addition to €2.7M raised in September and €1M in March from several angel investors. Modmo is led by 25-year-old Irishman Jack O’Sullivan who relocated to Vietnam to…
ROCKVILLE, Md., Feb. 4, 2022 /PRNewswire/ — Data for Cohort 1 with six months of follow-up from the Phase II ALTITUDE™ trial of RGX-314 for the treatment of diabetic retinopathy to be presented REGENXBIO Inc. (Nasdaq: RGNX) today announced that three oral presentations, including updated…
BRUSSELS and ATLANTA, Feb. 4, 2022 /PRNewswire/ — UCB, a global biopharmaceutical company, today announced positive topline results from the RAISE (NCT04115293) triali evaluating its investigational treatment zilucoplan, a self-administered, subcutaneous (SC) peptide inhibitor of…
DUBLIN, Feb. 4, 2022 /PRNewswire/ — The “Mobility as a Service Market by Service (Ride-Hailing, Car Sharing, Micro Mobility, Bus Sharing, Train), Solution, Application, Transportation, Vehicle, Operating System, Business Model, Propulsion & Region – Forecast to 2030” report has been…
SAN DIEGO, Feb. 4, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and Chief Executive Officer, Robert E. Hoffman will present a corporate…